Delayed Anemia after Treatment with Injectable Artesunate in the Democratic Republic of the Congo: A Manageable Issue

Cases of delayed hemolytic anemia have been described after treatment with injectable artesunate, the current World Health Organization (WHO)–recommended first-line drug for the treatment of severe malaria. A total of 350 patients (215 [61.4%] < 5 years of age and 135 [38.6%] ≥ 5 years of age) we...

Descripción completa

Detalles Bibliográficos
Autores principales: Burri, Christian, Ferrari, Giovanfrancesco, Ntuku, Henry Maggi, Kitoto, Antoinette Tshefu, Duparc, Stephan, Hugo, Pierre, Mitembo, Didier Kalemwa, Lengeler, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Tropical Medicine and Hygiene 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183412/
https://www.ncbi.nlm.nih.gov/pubmed/25071004
http://dx.doi.org/10.4269/ajtmh.14-0149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183412/
https://www.ncbi.nlm.nih.gov/pubmed/25071004
http://dx.doi.org/10.4269/ajtmh.14-0149

Ejemplares similares